Organisation-first access
Institutional identity, business details and the proposed research purpose would be reviewed before any catalogue is shown.
Private conceptNot accepting live orders or medical data
Verified research organisations only
Research supply needs a gate — not a disclaimer.
AsceticPharma will not use “research use only” as camouflage for consumer peptide sales. Organisation, purpose and product classification must be checked before catalogue access.
No consumer dosing content
No injection guidance, protocols, reconstitution instructions or therapeutic claims belong in this route.
Classification before sale
A “research” label does not decide legal status. Substance, presentation, claims and intended supply all matter.
Traceable documentation
Approved materials should carry batch identity and appropriate quality documentation without making unsupported purity claims.
Planned access flow
Four checks before catalogue access.
- 1Organisation
Verify the legal entity and institutional contact.
- 2Purpose
Record a credible, non-human research use.
- 3Classification
Review each material against UK medicines and chemicals rules.
- 4Approval
Issue account access with limits, records and review dates.
Direct-to-consumer peptide sales are not part of the compliant version.
Recent MHRA enforcement has specifically involved unlicensed peptide and weight-loss products. A checkout, “not for human use” text and attractive vial labels do not remove the risk when the real market and presentation point toward self-administration.
Read the MHRA enforcement notice ↗